ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap

Hans-Joachim Anders, Brad Rovin, David Jayne, Paul Brunetta, Rosanna Coppo, Anne Davidson, Satish Kumar Devarapu, Dick de Zeeuw, Jeremy Duffield, Dirk Eulberg, Alberto Fierro, Jürgen Floege, Steffen Frese, Loïc Guillevin, Stephen Holdsworth, Jeremy Hughes, Ralph Kettritz, Malte Kluger, Christian Krebs, Larissa Lapteva, Adeera Levin, Jinhua Li, Liz Lightstone, Matthias Mack, Ladan Mansouri, Stephen McAdoo, Eoin McKinney, Ulf Panzer, Samir Parikh, Charles Pusey, Chaim Putterman, Ton Rabelink, Andreas Radbruch, Andrew Rees, Mary Reilly, Marlies Reinders, Giuseppe Remuzzi, Piero Ruggenenti, Steven Sacks, Thomas J Schall, Catherine Meyer-Schwesinger, Kumar Sharma, Yusuke Suzuki, Nicola M. Tomas and Ming-Hui Zhao Medizinische Klinik and Poliklinik IV, Klinikum der Ludwig Maximilians Universität München, Munich, Germany; Ohio State University Wexner Medical Center, Columbus, Ohio, USA; Vasculitis and Lupus Clinic, Addenbrooke’s Hospital, Cambridge, UK; Development Team for Rituximab and Obinutuzumab Immunology, Genentech, South San Francisco, California, USA; AOU Città della Salute e della Scienza di Torino, Turin and Fondazione Ricerca Molinette, Regina Margherita Hospital, Turin, Italy; Center for Autoimmunity and Musculoskeletal Diseases, Feinstein Institute for Medical Research, Manhasset, New York, USA; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Research & Development, Biogen, Cambridge, Massachusetts, USA; NOXXON Pharma AG, Berlin, Germany; Clinica las Condes, Transplantation Unit, Santiago, Chile; Department of Nephrology and Clinical Immunology, University Hospital, Rheinisch Westfälische Technische Hochschule Aachen, Aachen, Germany; Evangelische Lungenklinik Berlin, Klinik für Thoraxchirurgie, Berlin, Germany; Université Paris Descartes and Hôpital Cochin, Paris, France; Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Clayton, Victoria, Australia; Medical Research Council Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK; Department of Nephrology and Critical-Care Medicine, Campus Virchow Klinikum and Experimental and Clinical Research Center, Charité Medical Faculty, Berlin, Germany; Zentrum für Innere Medizin, III. Medizinische Klinik und Poliklinik, University Medical Center, Hamburg, Germany; Division of Therapeutic Performance, Food and Drug Administration, Silver Spring, Maryland, USA; Division of Nephrology, University of British Columbia, Vancouver, Canada; Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia; Imperial AHSC Lupus Centre, Department of Medicine, Imperial College London, London, UK; Universität Regensburg, Klinik und Poliklinik für Innere Medizin II, Regensburg, Germany; Unit of Immunology and Allergy, Department of Medicine, Karolinska Institutet, and Karolinska University Hospital Solna, Stockholm, Sweden; Renal and Vascular Inflammation Section, Department of Medicine, Imperial College London, UK; Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke’s Hospital, Cambridge, UK; Division of Rheumatology, Albert Einstein College of Medicine, Bronx, New York, USA; Department of Nephrology, Leiden University Medical Center, Leiden, the Netherlands; Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Gemany; Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria; Pharmaceutical Development, Opsona Therapeutics Ltd., Dublin 2, Ireland; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Clinical Research Center for Rare Diseases Aldo and Cele Daccò, Bergamo, Italy; Unit of Nephrology and Dialysis, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy; MRC Centre for Transplantation Immunology and Mucosal Biology, King’s College London, UK; ChemoCentryx, Mountain View, California, USA; Center for Renal Translational Medicine, Institute of Metabolomic Medicine, University of California, San Diego, San Diego VA Healthcare System, La Jolla, California, USA; Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan; and Renal Division, Peking University First Hospital, Beijing, China